Standout Papers

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer ... 1996 2026 2006 2016 597
  1. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients (1996)
    Turid Aas, Anne‐Lise Børresen et al. Nature Medicine

Immediate Impact

8 by Nobel laureates 26 from Science/Nature 76 standout
Sub-graph 1 of 17

Citing Papers

The biology and management of non-small cell lung cancer
2018 StandoutNature
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
2 intermediate papers

Works of Anne‐Lise Børresen being referenced

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
1996 Standout
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains
1995

Author Peers

Author Last Decade Papers Cites
Anne‐Lise Børresen 1049 1005 363 673 56 2.3k
Koustubh Ranade 792 961 375 666 59 3.2k
Aaron D. Tward 1580 614 439 751 40 3.3k
Yun‐Yong Park 2121 831 412 797 70 3.4k
Bal L. Lokeshwar 1456 922 168 581 73 3.4k
Yohko Hikiba 1248 768 440 534 45 2.4k
Martin Highley 1167 895 511 511 60 3.0k
Yunus A. Luqmani 1191 929 270 593 66 2.4k
Daniel J. Gough 1571 1329 206 600 45 3.4k
Shiu‐Ru Lin 985 1047 342 775 84 2.5k
F. H. Sarkar 1644 1022 152 950 72 3.2k

All Works

Loading papers...

Rankless by CCL
2026